2021
DOI: 10.20471/acc.2021.60.02.01
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Cyclocryotherapy and Transscleral Diode Laser Cyclophotocoagulation in the Management of Refractory Glaucoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 20 publications
1
2
0
Order By: Relevance
“…Ten respondents (27.8%) have difficulty watching movies, sporting events or playing games. These findings from our questionnaire represent evidence of the minimal impact of cyclocryopexy on vision, the feeling of pain or discomfort from the patient's point of view, and the overall post-surgery comfort of the patient in the post-surgery period, as described in the work of Miljiković et al [17] from 2021. According to the questionnaire, 16 respondents underwent trabeculectomy (25%).…”
Section: Discussionsupporting
confidence: 69%
“…Ten respondents (27.8%) have difficulty watching movies, sporting events or playing games. These findings from our questionnaire represent evidence of the minimal impact of cyclocryopexy on vision, the feeling of pain or discomfort from the patient's point of view, and the overall post-surgery comfort of the patient in the post-surgery period, as described in the work of Miljiković et al [17] from 2021. According to the questionnaire, 16 respondents underwent trabeculectomy (25%).…”
Section: Discussionsupporting
confidence: 69%
“…A further 11 studies were later excluded: four because they were conference abstracts, two because there was no available outcome data, one because the study population was unqualified, and four because the TSCPC was conducted with an Nd: YAG laser. Thus, the meta‐analysis included nine articles for data extraction and analysis, including four (RCTs) (Liu & Tang, 2008; Miljkovic et al, 2021; Tzamalis et al, 2011; Wang et al, 2021) and five retrospective clinical controlled trials (Freigassner & Eckhardt, 2003; Goldenberg‐Cohen et al, 2005; Gorsler et al, 2015; Waibel et al, 2020; Zhang, 2010).…”
Section: Resultsmentioning
confidence: 99%
“…Even though there was no statistically significant difference between two procedures after 1 year, the mean difference in IOP decrease favoured the CCT group. However, only three studies provided information for 1 year (Freigassner & Eckhardt, 2003; Miljkovic et al, 2021; Tzamalis et al, 2011), and one study evaluated the IOP for more than 1 year postoperatively (Freigassner & Eckhardt, 2003), so the long‐term IOP‐lowering effect of the two procedures could not be systemically evaluated. Since the additional efficacy assessment in terms of antiglaucoma agent reduction, success rate, and retreatment rate did not differ significantly between the two groups, our study demonstrated that TSCPC and CCT appeared to provide comparable efficacy.…”
Section: Discussionmentioning
confidence: 99%